Escolar Documentos
Profissional Documentos
Cultura Documentos
PATIENT DETAILS
NAME
Mr:XYZ
AGE
52 yrs
SEX
IP No:
201010380
Wt
59 Kg
Ht
56
BMI
21
Dept
Pulmonary
DOA
25.9.12
DOD
31.9.12
S - SUBJECTIVE
O - OBJECTIVE
A - ASSESSMENT
P - PLAN
PROBLEM LIST
PROBLEM LIST
Pulmonary Tuberculosis
Diabetes Mellitus
SUBJECTIVE
REASON FOR ADMISSION
SOCIAL HISTORY
Alcoholic : Y
Tobacco:Y
(65kg to 59 kg)
Smoker :Y
Hemoptysis x 2 wks
Chest pain x 1 wk
Cotton industry
Father: TB-3 Yrs
OBJECTIVE
PHYSICAL EXAMINATION
General examination : P I C CL+E
Vital signs : Pulse rate:72/min
CVS
: S1S2 +VE
VITAL SIGNS
Days
Day1
Day2
Day3
Day4
Day5
Day6
Day7
Temp
101.5
100.5
100
99
98.5
98.5
98.5
BP
130/90
130/80
130/80
120/90
130/80
130/90
130/80
Pulse
72
72
72
72
72
72
72
BLOOD COUNT
Hb
13.5 gm/dl
TLC
6500 cells/cumm
ESR
20 mm/hr
Polymorph
74 %
Lymphocytes
34 %
Basophils
1%
Eosinophils
2%
Monocytes
2%
OTHER INVESTIGATIONS
Chest X-ray :Right lower lobe opacity
CT Scan of Thorax : Large consolidation with formation in right lower
lobe & upper lobe, Nodular lesion present
Sputum Examination: Presence of acid fast bacilli
Gram stain: Plenty of gram + ve cocci & occassionaly gram ve bacilli
Sputum Culture :
Organism isolated:
Staphylococcus species
SENSITIVE TO
RESISTANT TO
Amikacin
Cotrimoxazole
Cefuroxime
Netilmycin
Ceftriaxone
Ofloxacin
Clindamycin
ASSESSMENT
DIAGNOSIS
TUBERCULOSIS
ASSESSMENT
Etiology
Alcohol use
Heavy smoking
Diabetes mellitus
Family history : father
Malnutrition
Close contact with people infected with TB
Immunosuppressed patient
Indication for therapy
To control TB either by
DRUGS PRESCRIBED
DRUGS
DAYS OF TREATMENT
S.No
DOSE
T.Name
G.Name
D1
D2
D3
D4
D5
D6
D7
T.Monto 3
INH,Rifampin,
Ethambutol
300+450 +800mg
1-0-0
T.Pyzina
Pyrazinamide
750 mg
1-01
Neb.Duolin
Ipratropium Br/
Levosalbutamol
Inj.Oframax
Ceftriaxone
1gm bd
C.Yogut
1-0-1
T.Dolo
Paracetamol
650 mg 1-1-1
Syp.Linctus
codeine
Codeine
phosphate
2tsp tds
C. Becosules
Multivitamin
1-0-0
ALTERNATIVE THERAPY
DRUGS
DOSE
Cyclosporin
250 mg od
PAS
200 mg od
Amikacin
500 mg od
Kanamycin
500 mg od
Capreomycin
1 g od
PLAN
Discharge Medications
DRUGS
DOSE
T. INH,Rifampin,Ethambutol
300+450+800 mg1-0- 0
T.Pyrazinamide
750 mg
C.Multivitamin
1-0-0
1-01
GOALS OF THERAPY
General goals
To cure patient
Restore QOL
Prevent relapse
Reduce transmission
Patient specific goals
Reduce fever, cough, chest pain, hemoptysis.
To maintain normal weight
Goals achieved
Temperature reduction
Symptoms relieved
Patients conditions improved
Monitoring parameter
THERAPEUTIC MONITORING & TOXICITY MONITORING
Chest radiography
Isolation of mycobacterium
Hepatitis
Rashes
CT scan of thorax
Hematological test
Tuberculin test
Thoracotomy
Interferon gamma release assay
DNA based testing
Constipation
Hyperuricemia
Points to physician
Points to patient
Assess adherence to
regimen
Rifampin-orange colouration
About disease
About drugs
SUBJECTIVE
Polyuria
Polypdipsia
Fatigue
OBJECTIVE
Blood sugar
mgs/dl
Day 1
Day 3
Day 5
Day 7
FBS
160
145
144
90
RBS
200
195
185
170
PPS
180
170
175
163
OBJECTIVE
RENAL FUNCTION TEST
Urea
25
Scr. Creatine
0.8
ELECTROLYTES (m.Eq/L)
Sodium
Potassium
135
4
Chloride
99
Bicarbonates
26
URINE EXAMINATION
URINE EXAMINATION
Colour
Pale yellow
Sugar
++ ve
Bile salts
-ve
WBC
Nil
Bile pigment
-ve
RBC
Nil
Albumin
++ ve
Casts
Nil
Pus cells
2-3
Epithelial cells
2-3
ASSESSMENT
Diagnosis: Diabetes
Etiology
Family history-mother (5yrs)
Indication for therapy
Normalize the blood glucose level
Symptoms to be controlled
Assessment of therapy
DRUGS
DOSE
DAYS
Inj. Insulin
30/70 1-0-1
D1- D7
T. Glimeperide
1mg od
D1- D7
PLAN
Discharge medications
Inj. Insulin
-30/70 units
T.Glimeperide - 1mg od
Goals of therapy
Eliminate symptoms
Prevent long term complications
Patient specific goals
To reduce fatigue, polyuria, polydipsia
Goals achieved
Blood glucose level reduced
Improvement in patient condition
Monitoring parameter
Hypoglycemia
Glycosylated Hb
Diarrhea, nausea,vomiting
Points to physician
Glimiperide + rifampin
Consult the current references
For normal values
Exercise
Foot care
Points to patient
Diet
Hygiene
Blood sugar monitoring
About disease
About drugs
Follow up
Review after 15 days-test
THANK YOU